Khondrion receives EMA agreement on its Paediatric Investigation Plan for sonlicromanol
18 janv. 2021 02h00 HE
|
Khondrion
Khondrion receives EMA agreement on its Paediatric Investigation Plan for sonlicromanol NIJMEGEN, the Netherlands – 18 January, 2021: Khondrion, a clinical-stage biopharmaceutical company...